Safety and efficacy of rituximab in refractory noninfectious uveitis and scleritis

Faris M. Al Ghulaiga, Ibrahim Alharbi, Abdulrahman F. Albloushi, Abdulsalam M. Dheyab, Marwan A. Abouammoh, Ahmed M. Abu El-Asrar

Open source

DOI
10.1186/s12348-025-00522-5
Published
2025-09-26
Container
Journal of Ophthalmic Inflammation and Infection
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12348-025-00522-5,
  title = {Safety and efficacy of rituximab in refractory noninfectious uveitis and scleritis},
  author = {Faris M. Al Ghulaiga and Ibrahim Alharbi and Abdulrahman F. Albloushi and Abdulsalam M. Dheyab and Marwan A. Abouammoh and Ahmed M. Abu El-Asrar},
  year = {2025},
  journal = {Journal of Ophthalmic Inflammation and Infection},
  doi = {10.1186/s12348-025-00522-5},
  url = {https://doi.org/10.1186/s12348-025-00522-5}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of rituximab in refractory noninfectious uveitis and scleritis
AU  - Faris M. Al Ghulaiga
AU  - Ibrahim Alharbi
AU  - Abdulrahman F. Albloushi
AU  - Abdulsalam M. Dheyab
AU  - Marwan A. Abouammoh
AU  - Ahmed M. Abu El-Asrar
PY  - 2025
JO  - Journal of Ophthalmic Inflammation and Infection
DO  - 10.1186/s12348-025-00522-5
UR  - https://doi.org/10.1186/s12348-025-00522-5
ER  - 

APA

Ghulaiga, F. M. A., Alharbi, I., Albloushi, A. F., Dheyab, A. M., Abouammoh, M. A., & El-Asrar, A. M. A. (2025). Safety and efficacy of rituximab in refractory noninfectious uveitis and scleritis. Journal of Ophthalmic Inflammation and Infection. https://doi.org/10.1186/s12348-025-00522-5

Source records